Friedenthal Financial Makes New Investment in Doximity, Inc. (NASDAQ:DOCS)

Friedenthal Financial acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 18,342 shares of the company's stock, valued at approximately $799,000.

Several other hedge funds also recently bought and sold shares of the company. RFG Advisory LLC lifted its holdings in Doximity by 6.0% in the 1st quarter. RFG Advisory LLC now owns 24,726 shares of the company's stock worth $665,000 after buying an additional 1,401 shares during the period. Oak Thistle LLC purchased a new position in shares of Doximity during the 1st quarter worth about $323,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Doximity during the first quarter worth $583,000. State of Michigan Retirement System boosted its holdings in shares of Doximity by 6.0% in the first quarter. State of Michigan Retirement System now owns 30,000 shares of the company's stock valued at $807,000 after purchasing an additional 1,700 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. bought a new stake in shares of Doximity in the 1st quarter valued at about $416,000. Hedge funds and other institutional investors own 87.19% of the company's stock.

Insider Buying and Selling

In other news, Director Kira Scherer Wampler sold 2,500 shares of the company's stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $28.18, for a total value of $70,450.00. Following the sale, the director now directly owns 10,258 shares of the company's stock, valued at approximately $289,070.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $28.18, for a total value of $70,450.00. Following the completion of the sale, the director now owns 10,258 shares in the company, valued at $289,070.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the company's stock in a transaction on Monday, August 5th. The shares were sold at an average price of $25.54, for a total value of $25,820.94. Following the sale, the director now owns 11,258 shares of the company's stock, valued at approximately $287,529.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,451 shares of company stock worth $1,201,018. 39.40% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

DOCS has been the topic of several research reports. Wells Fargo & Company downgraded shares of Doximity from an "equal weight" rating to an "underweight" rating and cut their price target for the stock from $27.00 to $19.00 in a report on Thursday, July 18th. Evercore ISI upped their target price on shares of Doximity from $34.00 to $45.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Baird R W raised Doximity to a "strong-buy" rating in a research report on Tuesday, September 17th. JPMorgan Chase & Co. upped their target price on Doximity from $27.00 to $30.00 and gave the company a "neutral" rating in a research report on Monday, August 19th. Finally, Canaccord Genuity Group increased their price target on shares of Doximity from $37.00 to $40.00 and gave the stock a "buy" rating in a report on Tuesday, August 20th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $35.83.

Doximity Stock Up 1.5 %

DOCS stock traded up $0.64 during midday trading on Friday, reaching $43.50. 914,597 shares of the company's stock traded hands, compared to its average volume of 1,696,667. Doximity, Inc. has a 1-year low of $19.89 and a 1-year high of $44.88. The company has a market cap of $8.07 billion, a price-to-earnings ratio of 60.42, a PEG ratio of 5.29 and a beta of 1.29. The company has a 50-day simple moving average of $39.47 and a two-hundred day simple moving average of $31.27.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. Doximity had a return on equity of 19.26% and a net margin of 32.53%. The business had revenue of $126.68 million during the quarter, compared to analysts' expectations of $119.88 million. Equities research analysts forecast that Doximity, Inc. will post 0.8 EPS for the current year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.